Mead Johnson Nutrition Co 4

Accession 0001209191-17-016294

CIK 0001452575operating

View on SEC.gov Company Profile

Filed

Mar 1, 7:00 PM ET

Accepted

Mar 2, 11:18 AM ET

Size

21.8 KB

Accession

0001209191-17-016294

Insider Transaction Report

Form 4

Period: 2017-02-28

Mead Johnson Nutrition CoMJN

Jakobsen Peter Kasper

President, Americas

Transactions

Award
Restricted Stock Unit (RSU)
2017-02-28+46,801→ 46,801 total
From: 2020-02-28Exp: 2020-02-28→ Common Stock (46,801 underlying)
Award
Restricted Stock Unit (RSU)
2017-02-28+31,201→ 31,201 total
Exp: 2020-02-28→ Common Stock (31,201 underlying)
Exercise/Conversion
Performance Shares
2017-02-28−18,053→ 0 total
From: 2017-02-28Exp: 2017-02-28→ Common Stock (18,053 underlying)
Exercise/Conversion
Common Stock
2017-02-28+18,053→ 75,775 total
Award
Performance Shares
2017-02-28+7,156→ 18,053 total
From: 2017-02-28Exp: 2017-02-28→ Common Stock (7,156 underlying)
Tax Payment
Common Stock
2017-02-28$87.79/sh−8,251$724,355→ 67,524 total
Award
Performance Shares
2017-02-28+9,403→ 9,403 total
→ Common Stock (9,403 underlying)
Award
Performance Shares
2017-02-28+6,711→ 6,711 total
→ Common Stock (6,711 underlying)

Footnotes (10)

[F1]Represents shares of common stock withheld for payment of taxes upon the vesting of performance shares.
[F10]Each performance share will convert into one share of common stock upon vesting and settlement in the first quarter of 2019.
[F2]Each restricted stock unit represents the contingent right to receive one share of common stock.
[F3]One-third of the restricted stock unit award will vest on each of the first, second and third anniversaries of the grant date.
[F4]The derivative securities were granted to the reporting person, and were not sold to the reporting person. As such, the reporting person did not pay any consideration for the derivative securities.
[F5]Represents the current tranche of performance shares earned under the 2014 - 2016 performance share award as of February 28, 2017, at which date the Compensation and Management Development Committee certified the extent to which the 2016 performance criteria were met. Each earned performance share represents the contingent right to receive one share of common stock.
[F6]Each performance share represents the contingent right to receive one share of common stock. This transaction represents the settlement of vested performance shares in shares of common stock.
[F7]Represents the current tranche of performance shares earned under the 2015 - 2017 performance share award as of February 28, 2017, at which date the Compensation and Management Development Committee certified the extent to which the 2016 performance criteria were met. Each earned performance share represents the contingent right to receive one share of common stock.
[F8]Each performance share will convert into one share of common stock upon vesting and settlement in the first quarter of 2018.
[F9]Represents the current tranche of performance shares earned under the 2016 - 2018 performance share award as of February 28, 2017, at which date the Compensation and Management Development Committee certified the extent to which the 2016 performance criteria were met. Each earned performance share represents the contingent right to receive one share of common stock.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Mead Johnson Nutrition Co

CIK 0001452575

→

Entity typeoperating

IncorporatedDE

Related Parties

filerCIK 0001452575

Filing Metadata

Form type: 4
Filed: Mar 1, 7:00 PM ET
Accepted: Mar 2, 11:18 AM ET
Size: 21.8 KB

View on SEC.gov